"You cannot tell the story of modern biology without him." "True," the other researcher says, flipping through old photos of lab notebooks and conference programs, "but you also cannot tell it cleanly." That is the argument sitting in the room whenever James D. Watson comes up - not whether he mattered, because he obviously did, but what to do with a scientific legacy that arrived carrying both a torch and a box of matches [1].

The Molecule That Stopped Playing Hard to Get

Watson died in November 2025 at age 97, and the obituary by Jan Witkowski and Bruce Stillman reads like a guided tour through half the architecture of modern biology [1]. The headline achievement is the one every high school textbook has been dining out on for decades: in 1953, Watson and Francis Crick helped describe DNA's double-helix structure. Suddenly heredity was not an abstract family rumor passed down by peas and eyebrows. It was chemistry. It had shape. It had rules.

That mattered because structure is not decorative in biology. Structure is plot. Once scientists could think about DNA as two paired strands carrying information in a way cells could copy, the whole field got a better map. A lot of 20th century biology was basically researchers chasing this elegant spiral around the building like detectives who had finally found the suspect's shoeprint.

And yes, this story is inseparable from Rosalind Franklin's X-ray diffraction work and the long, uncomfortable history of who got credit, who got sidelined, and who got mythologized into a statue with suspiciously selective memory. Science loves to present itself as a serene march of reason. In practice it often behaves like a newsroom with better glassware.

He Did Not Just Discover Things - He Built the Stage

The PNAS obituary makes a second point that gets less airtime and may be just as important: Watson was not only a famous scientist, he was a serial institution-builder [1]. At Cold Spring Harbor Laboratory, he helped turn the place into a powerhouse for molecular biology, cancer research, education, and neuroscience training. If the double helix was his firework, Cold Spring Harbor was the electrical grid he helped wire afterward.

Big discoveries get the posters. Institutions shape who gets trained, what questions feel worth asking, and which weird young scientist gets enough coffee and microscope time to become tomorrow's problem for everyone else. Watson also wrote Molecular Biology of the Gene, a textbook that helped make biology feel alive rather than embalmed [1]. Plenty of scientists leave papers behind. Fewer leave behind the intellectual furniture people keep using for generations.

From DNA Ladder to Genome Warehouse

Watson also pushed early on for the Human Genome Project, which aimed to read humanity's full DNA instruction book. That project looked absurdly ambitious at the time, a bit like announcing you are going to count every grain of sand on a beach. Yet it happened, and its aftershocks are still rolling through medicine and biology.

Recent reviews show how far that legacy has stretched. The original human reference genome turned out to be incomplete and not very representative of human diversity, so newer work has moved toward gap-free sequences and pangenomes that better reflect real human variation [2,3]. The first map was revolutionary, but it still had blank spaces where the cartographer had basically written "here be genomic headaches."

That matters in the clinic. Genomic medicine now shapes diagnosis, risk prediction, and treatment in ways that would have sounded like science fiction back when DNA models were being built from metal bits and stubbornness [6]. But the newer literature also keeps repeating the same warning in increasingly polite academic language: if genomic data come mostly from some populations and not others, precision medicine gets imprecise fast [5]. A medical crystal ball trained on a narrow slice of humanity is still a very fancy bias machine.

The Genius Problem

Here is the hard part. Watson's career also became a case study in how scientific brilliance does not grant moral clarity or even the basic good sense to stop talking when you are saying harmful nonsense. His repeated racist and sexist remarks did real damage to his public standing and to the culture around genetics. That is not a footnote. It is part of the file.

Oddly, the obituary itself helps explain why this matters beyond biography. Watson pushed to include ethical, legal, and social issues in genome research from the beginning [1]. That thread has since grown into a substantial field examining privacy, discrimination, equity, and the lingering shadow of eugenics [4]. So his legacy loops back on itself in a very brain-like way: one part of it helped accelerate modern genomics, and another part became a reminder of why genomics needs guardrails, humility, and adults in the room.

That may be the real reason this obituary is worth reading. It is not just about one famous man with a Nobel Prize and a talent for detonating a dinner conversation. It is about how science actually changes the world - through ideas, labs, funding, textbooks, ambition, ego, and arguments that never quite end. Watson helped crack open the molecule at the center of heredity. The generations after him are still deciding what to do with the door.

References

1. Witkowski J, Stillman B. James D. Watson (1928-2025): Influencer of science and society. Proc Natl Acad Sci U S A. 2026. doi:10.1073/pnas.2600779123. PubMed: https://pubmed.ncbi.nlm.nih.gov/41642975/
2. Attwaters M. The final pieces of the human genome. Nat Rev Genet. 2022;23(6):321. doi:10.1038/s41576-022-00494-5. PubMed: https://pubmed.ncbi.nlm.nih.gov/35488041/
3. Schatz MC, et al. Beyond the Human Genome Project: The Age of Complete Human Genome Sequences and Pangenome References. Annu Rev Genomics Hum Genet. 2024. doi:10.1146/annurev-genom-021623-104241. PubMed: https://pubmed.ncbi.nlm.nih.gov/38663087/
4. Dolan SM, et al. Three decades of ethical, legal, and social implications research: Looking back to chart a path forward. Cell Genom. 2022;2(8):100150. doi:10.1016/j.xgen.2022.100150. PMCID: https://pmc.ncbi.nlm.nih.gov/articles/PMC9352173/
5. Fatumo S, Chikowore T, Choudhury A, Ayub M, Martin AR, Kuchenbaecker K, et al. A roadmap to increase diversity in genomic studies. Nat Med. 2022;28(2):243-250. doi:10.1038/s41591-021-01672-4. PubMed: https://pubmed.ncbi.nlm.nih.gov/35145307/
6. Manolio TA, Rupert A, Narula J, Bult CJ, Chisholm RL, Ginsburg GS, et al. Genomic medicine year in review: 2025. Am J Hum Genet. 2025;112(12):2822-2825. doi:10.1016/j.ajhg.2025.11.001. PubMed: https://pubmed.ncbi.nlm.nih.gov/41349511/

Disclaimer: The image accompanying this article is for illustrative purposes only and does not depict actual experimental results, data, or biological mechanisms.